Sai Life Sciences has allotted 11,100 equity shares under ESOP on 24 March 2026. With this allotment, the paid up equity share capital has increased to 21,17,79,234 equity shares of Re 1 each. Powered by Capital Market - Live News

Sai Life Sciences has allotted 129,007 equity shares under ESOP on 22 February 2026. With this allotment, the paid up equity share capital has increased to 21,17,58,134 equity shares of Re 1 each. Powered by Capital Market - Live News

Net profit of Sai Life Sciences rose 86.41% to Rs 100.38 crore in the quarter ended December 2025 as against Rs 53.85 crore during the previous quarter ended December 2024. Sales rose 26.53% to Rs 556.46 crore in the quarter ended December 2025 as against Rs 439.78 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales556.46439.78 27 OPM %33.7627.23 - PBDT186.53105.74 76 PBT142.4671.65 99 NP100.3853.85 86 Powered by Capital Market - Live News

Sai Life Sciences will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live News

Sai Life Sciences has allotted 8,89,133 equity shares under ESOP on 19 December 2025. Powered by Capital Market - Live News